* Immunocore Holdings PLC IMCR.OQ reported quarterly
breakeven
results per share for the quarter ended in June. The mean
expectation of twelve analysts for the quarter was for a loss
of 32 pence per share.
* Revenue rose 89.7% to £60.70 million from a year ago;
analysts
expected £46.46 million.
* Immunocore Holdings PLC's reported EPS for the quarter was
breakeven results.
* The mean earnings estimate of analysts had fallen by
about 1.4%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
* Immunocore Holdings PLC shares had risen by 6.8% this
quarter and gained 12.2% so far this year.
* The company reported a quarterly loss of £17.89 million.
* Wall Street's median 12-month price target for Immunocore
Holdings PLC is $80.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 10 at 01:32 p.m. UTC. All figures in pounds unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.32 0.00 Beat
Mar. 31 2023 -0.32 -0.35 Missed
Dec. 31 2022 0.00 -0.54 Missed
Sep. 30 2022 -0.29 0.12 Beat